Advertisement
News
Advertisement

Biogen's Avonex Pen gets European OK

Tue, 06/07/2011 - 10:35am
Mass High Tech: The Journal of New England Technology

After receiving a positive recommendation in April from a European regulatory panel, Biogen Idec Inc. has won approval from the European Commission for its Avonex Pen to treat patients with relapsing multiple sclerosis.

The Avonex Pen is the self-administered form of the Weston biotech’s Avonex MS drug and requires once-weekly injections of the treatment.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading